Search Results (1 to 10 of 3009 Results)
Download search results: CSV END BibTex RIS
Skip search results from other journals and go to results- 851 Journal of Medical Internet Research
- 541 JMIR Research Protocols
- 308 JMIR Formative Research
- 256 JMIR mHealth and uHealth
- 135 JMIR Public Health and Surveillance
- 117 Online Journal of Public Health Informatics
- 107 JMIR Mental Health
- 94 JMIR Medical Informatics
- 79 JMIR Dermatology
- 72 JMIR Human Factors
- 58 JMIR Cancer
- 48 JMIR Pediatrics and Parenting
- 47 JMIR Medical Education
- 44 JMIR Serious Games
- 38 JMIR Aging
- 30 Interactive Journal of Medical Research
- 29 JMIR Perioperative Medicine
- 26 JMIR Diabetes
- 22 JMIR Rehabilitation and Assistive Technologies
- 19 JMIR Cardio
- 18 Iproceedings
- 15 JMIR Infodemiology
- 10 JMIR AI
- 10 JMIRx Med
- 10 Journal of Participatory Medicine
- 8 JMIR Nursing
- 7 JMIR Bioinformatics and Biotechnology
- 4 JMIR Biomedical Engineering
- 2 Asian/Pacific Island Nursing Journal
- 2 Medicine 2.0
- 1 JMIR Neurotechnology
- 1 JMIR XR and Spatial Computing (JMXR)
- 0 iProceedings
- 0 JMIR Preprints
- 0 JMIR Challenges
- 0 JMIR Data
- 0 JMIRx Bio
- 0 Transfer Hub (manuscript eXchange)
deal: samen werken aan duurzame zorg [Article in Dutch](https://www.rvo.nl/sites/default/files/2024-12/C-
J Med Internet Res 2025;27:e67538
Download Citation: END BibTex RIS
Go back to the top of the page Skip and go to footer section
Go back to the top of the page Skip and go to footer section
Go back to the top of the page Skip and go to footer section
Go back to the top of the page Skip and go to footer section
Go back to the top of the page Skip and go to footer section
Go back to the top of the page Skip and go to footer section
Several recent Canadian population-based studies have shown that many patients at high CVD risk continue to have low-density lipoprotein cholesterol (LDL-C) levels well above the guideline targets [2,3]. LDL-C has been extensively studied and described as a causal factor for CVD [4]. LDL-C levels above the target can result from multiple factors such as insufficient LDL-C lowering with statins, statin-related side effects, suboptimal medication adherence, and treatment inertia [5].
JMIR Cardio 2025;9:e58124
Download Citation: END BibTex RIS
Applications of AI in Predicting Drug Responses for Type 2 Diabetes
The studies were first filtered for “type 2 diabetes” and then for other disease areas such as arthritis, multiple sclerosis, and cardiovascular diseases (Figure 1 A-C). These additional conditions were chosen because they are widely studied in relation to drug response and represent areas where AI methods have shown emerging applications.
JMIR Diabetes 2025;10:e66831
Download Citation: END BibTex RIS
Go back to the top of the page Skip and go to footer section